ICICI Venture Funds Management Company today said it has sold the animal healthcare division of RFCL, Vetnex, to Pfizer Animal Health for an undisclosed sum.
The sale is expected to close by August 2009, ICICI said in a release. Terms of the agreement were not disclosed.
"RFCL is a classic ICICI Venture buyout, involving the divestiture of a non-core business of a large corporate along with participation from the managerment team of the business," ICICI Venture MD & CEO Vishakha Mulye said in a release.
In 2005, ICICI Venture bought RFCL from Ranbaxy. RFCL had three divsions — fine chemicals, diagnositcs and animal healthcare (Vetnex).
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app